In an unprecedented medical breakthrough, doctors developed and deployed a tailor-made CRISPR treatment to combat a newborn’s life‐threatening metabolic disorder. The rapid, bespoke therapy marks a pivotal moment in personalized medicine and could signal a new era for addressing rare genetic conditions.
Back to Top / Thursday, May 15, 2025, 1:21 pm / permalink 4812 / 4 stories in 9 months
New Research Suggests Caffeine May Slow Cellular Aging Process / 8 months
Paradromics Completes First Human Brain Implant Test Successfully / 9 months
Infrared contacts promise night vision through closed lids / 9 months
New AI Model Predicts Over 1000 Diseases Early / 5 months
Neuralink Secures $650M in Latest Funding Round / 9 months
IVFmicro secures £3.5M to boost IVF treatment technology / 2 months
Sofinnova Partners Closes €650M Biopharma & MedTech Fund / 3 months
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.